Skip to main content
Midas Edge

Annovis Bio, Inc.

For the period ended Nov 12, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 12, 2025 · Filed Nov 13, 2025

Use the contents to explore the available documents and sections.

ANVS$0.84+26.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99 · Forward-Looking Statements

Forward-Looking Statements

This press release contains forward-looking statements under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Actual results may differ due to various risks and uncertainties, including those outlined in the Company’s SEC filings under “Risk Factors” in its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update forward-looking statements except as required by law.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.